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Abstract
Malaria was introduced to Europe from the southeast during the Neolithic period and 
subsequently became established throughout the continent, due to the combination of 
favorable geomorphological and climatic conditions with the presence of adequately 
sized human and competent vector populations. Plasmodium vivax, P. malariae and P. fal-
ciparum all occurred in various areas of the continent, transmitted by numerous Anopheles 
species, mainly An. atroparvus in the northwest, An. labranchiae and An. sacharovi in the 
south. The height of malaria endemicity in the Early Modern Age was followed by decline 
in the twentieth century, particularly in the northwest, owing mainly to man-made 
contraction of vector breeding sites and improvement of living standards. Eradication 
was accomplished in 1974 through widespread drug treatment and residual insecticide 
spraying. Since then, despite the sustained presence of competent vectors and numerous 
malaria cases imported by travelers and immigrants, autochthonous transmission has 
been sporadic in Europe, probably due to prompt diagnosis and treatment afforded by 
robust healthcare services. Current and projected climatic conditions are conducive to 
malaria transmission, particularly vivax malaria, in several areas of Southern Europe. 
Moreover, the continuing immigration crisis may facilitate the buildup of an infectious 
parasite reservoir in the area. Although malaria resurgence is currently unlikely particu-
larly in northwest Europe, it is of crucial importance to maintain disease awareness, diag-
nostic and clinical competence and robust public health infrastructure for surveillance 
and vector control to diminish the possibility of malaria transmission in Europe’s most 
vulnerable areas.
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1. Introduction
Malaria, the most notorious parasitic disease of mankind, has accompanied humanity probably 
since prehistoric times and has shaped the course of human history over the centuries. It is still 
a major infectious disease today, causing more deaths by far than all other parasitic diseases 
combined, while nearly half of the current human population lives in areas of ongoing trans-
mission. According to the World Health Organization (WHO) in 2016, 216 million malaria cases 
occurred worldwide (uncertainty range 196–263 million) resulting in 445,000 deaths. At pres-
ent, 90% of all cases and 91% of all malaria deaths (of which 70% are in children under 5 years) 
occur in the WHO African Region [1]. Five species of the parasitic protozoan Plasmodium cause 
malaria: P. falciparum, P. vivax P. ovale, P. malariae and P. knowlesi. The ecology of human malaria 
species is closely linked to geomorphology and climatic conditions, particularly temperature 
and rainfall, which affect both the vector species and the parasites themselves, while malaria 
epidemiology is influenced by additional factors relating to the human host, such as popula-
tion density and susceptibility to infection. Ronald Ross developed the original mathematical 
models for malaria transmission in the early twentieth century and his equations were refined 
by George McDonald and several mathematicians and other scientists for over 70 years. These 
models expanded further using epidemiological and entomological data from field studies, 
eventually evolving into the Ross-MacDonald theory of mosquito-borne disease transmission 
[2]. These equations still form the basis of our understanding of malaria transmission and, 
despite some rather simplifying assumptions they contain, they epitomize its most important 
determinants. In one of them MacDonald defined the concept now called the basic reproduc-
tion number R
0
 as the expected number of secondary infections resulting from a single infec-
tion in a completely susceptible population. He denoted it as follows [3]:
  R 
0
  =  ma 2  bp n  / − r ln p (1)
where m is defined as Anopheles mosquito abundance relative to the human population, a 
describes the inclination of a vector to bite a human host, b represents the proportion of infective 
mosquito bites, p is defined as the probability the mosquito will survive a day, n is defined as the 
duration of the extrinsic incubation period, that is, time needed for parasite development within 
the mosquito and r is the recovery rate of the human host. If R
0
 is greater than one, the number 
of infected people increases, and if it is less than one, that number declines. In terms of these 
models, one can surmise that for malaria to invade and remain established in a certain area, 
where geomorphology, temperature and precipitation favor parasite, and vector survival and 
development, an adequately sized susceptible human population must coexist with efficient 
malaria vectors. Efficiency depends on mosquito abundance, life span, predilection for feeding 
on human host and susceptibility to infection by the various Plasmodium species. These deter-
mining factors for malaria risk in a given area were described in detail within the definitions of 
receptivity, vector infectivity and vulnerability. Each of these factors and their respective roles in 
the establishment and the eradication of malaria from the European World are briefly discussed.
Several Anopheles species capable of transmitting malaria exist in Europe. Species belonging to 
the Anopheles maculipennis Subgroup (Diptera, Culicidae) are widely distributed and exhibit 
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variable susceptibility to infection by Plasmodium spp., due to differences in behavioral pat-
terns and feeding preferences. This subgroup includes 10 species among which 3 are important 
malaria vector species, that is, An. atroparvus (van Thiel 1927) in most of western, northern and 
central Europe, An. labranchiae (Falleroni 1926) and An. sacharovi (Favre 1903) in the south and 
southeast. Other species, occurring in Europe that are considered as malaria vectors of minor 
importance, include An. messeae, An. maculipennis s.s. and An. melanoon of the Maculipennis 
Subgroup, while some are of little significance such as An. algeriensis, An. claviger, An. plumbeus, 
An. superpictus to cite a few [4, 5]. The most important geographical features regarding malaria 
ecology in Europe were the plains and coastal marshes in all areas of the continent. Southern 
Europe is comprised of mountainous peninsulas, separated by stretches of sea that make up 
the Mediterranean. In each of these, mountain ranges divide plains, where water from rain-
fall tended to collect and frequently stagnate, forming marshes on its way to the sea. Coastal 
marshlands also existed all around the North Sea basin while there are numerous river valleys 
and flood plains in Central and Northwest Europe. European climatic conditions, particularly 
the extreme seasonality of temperate climate, presented a substantial challenge for Plasmodium 
species during their gradual spread across the continent, although the distribution of P. vivax in 
Europe until the twentieth century extended as north as Southern Finland [6]. Optimal tempera-
ture ranges for parasite development within the mosquito are 16–33 and 18–33°C for P. vivax and 
P. falciparum, respectively [7]. Evidently, European winter temperatures were not conducive to 
parasite development. Temperate Plasmodium strains circumvented this problem by employing 
biological mechanisms to ensure survival and maintain transmission during the winter. P. vivax 
relies primarily on dormancy in the human liver in the form of hypnozoites, whereas P. malariae 
on prolonged incubation and persistent low-level parasitemia for years or even decades. An 
additional opportunity for continued parasite survival and transmission was the overwintering 
of female mosquitoes indoors, in the warmth of animal shelters and human dwellings.
2. Introduction, rise and decline of malaria in Europe
It is most likely that malaria (caused by P. vivax, P. malariae and P. falciparum) was introduced 
into the area around the Mediterranean and thence to the rest of Europe during the Neolithic 
period (4000–3000 BC). P. falciparum’s histidine-rich protein 2 was detected in Egyptian mum-
mies from 3200 BC confirming its presence in the outskirts of the Mediterranean world in 
the fourth millennium BC, suggesting the known contact between Egypt and Greece in the 
Early Bronze Age as one possible route of its introduction to Europe. Another possibility is 
that all three species of Plasmodium made the crossing within human hosts, as populations of 
Neolithic farmers migrated to Europe from the Near East, the wetlands and plains of today’s 
Israel, Palestine, Syria and Jordan, where agriculture is believed to have developed [8].
Attempts to trace the history of malaria in ancient Greece before the fifth century BC are 
plagued by shortage of evidence and confounded by difficulties in its interpretation. There is 
an interesting passage in Homer’s Iliad in which Achilles hurrying to avenge Patroclus’ death is 
compared to the bright star that rises in late July (Sirius) and heralds the arrival of fever (greek 
“πυρετός”) for wretched mortals. Although impossible to prove that this is an early reference 
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to malaria, the association with the harvest calls to mind the name “aestivo-autumnal fever” 
frequently used for P. falciparum malaria by doctors many centuries later. However, the clear-
est references from historic sources that can be attributed to malaria are those to fevers with 
tertian and quartan periodicities. Hippocrates in the fifth and fourth centuries BC and Celsus 
in the early first century AD described two types of tertian fever (tertian and semitertian) with 
symptoms corresponding to vivax and falciparum malaria respectively and a quartan fever 
corresponding to infection by P. malariae. The association with swamps was also common 
knowledge since the time of Hippocrates’ treatise “Airs, Waters, Places” although the connec-
tion with mosquitoes was not made, possibly because of the existence of regions where there 
was no malaria although mosquitoes were abundant. P. vivax was always the most important 
species in the area, as its life cycle characteristics and adaptations were well suited for trans-
mission in the seasonal climate of the Mediterranean, but malaria due to P. falciparum and 
`P. malariae occurred as well, unlike P. ovale which is absent from the Mediterranean region. 
Vivax malaria appeared in spring and early summer, followed by falciparum malaria, which 
peaked in late summer and autumn. Periodic epidemics were also observed in areas of ende-
micity. Malaria was well known at the time of the Roman Empire. The Pontine Marshes, a 
30 km2 marshland area to the southeast of Rome in central Italy, was a haven for the disease 
for almost two millennia. The word “malaria” itself, meaning “bad air” (mal’aria) is Italian in 
origin and reflects the miasmatic theory on the nature of the disease. Julius Caesar, who had 
suffered from quartan fever himself when he was young, had ambitious plans to drain the 
Pontine Marshes and claim the land for agriculture, a feat that was finally accomplished by 
Mussolini, on the eve of World War II. Eminent Byzantine physicians, such as Oribasius and 
Paul of Aegina, provide information on fevers during the Middle Ages in the Eastern Roman 
Empire (Byzantium) [9].
P. vivax and P. malariae gradually made their way to the north-west and the north of the con-
tinent, probably through France and Spain. Little is known about the first centuries of the first 
millennium AD, but there can be no doubt that malaria was present in northwest Europe from 
the middle Ages until the nineteenth century. During the medieval climatic optimum, near 
the end of the twelfth century, increased temperatures and associated rise in sea level prob-
ably favored the spread of malaria northward. The coastal flood plains and marshlands in the 
Iberian Peninsula, France, England, the Netherlands, North Germany, Denmark, Scandinavia 
and Russia were most affected. A significant vector for coastal areas was the zoophilic An. 
atroparvus, a widely distributed species. Once established on the coast, malaria strains could 
move inland along river valleys, floodplains and swamps, possibly transmitted by inland 
mosquito species, such as An. messeae. Assessment of disease incidence and mortality from 
historical records is difficult. Nevertheless, evidence that malaria was the likely cause of fever 
in European coastal marshes can be gathered from accounts of disease symptoms, such as 
intermittent fevers (tertian and quartan), anemia and splenomegaly and by its seasonal pat-
tern. Such descriptions exist in Anglo-Saxon medical texts dating back to the ninth century 
and can be found in accounts from north Germany, Denmark and the Netherlands. P. malariae 
is believed to have been endemic along the river banks of the Rhine, Rhone and Danube, 
along the eastern and southeastern English coast, and in the Netherlands and as far north as 
Sweden and Finland in the thirteenth century [10]. It appears that falciparum malaria was 
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rarely encountered in northwest Europe and when it did, it was probably imported from the 
south and could not really take root, as its causative agent, P. falciparum did not survive within 
the human host for more than a year and was poorly adapted to local mosquito species.
Malaria reached the height of its endemicity in northwest and north Europe in the Early 
Modern Age (late fifteenth and early sixteenth centuries), mainly due to high population den-
sities in coastal areas and a variety of human interventions, like the construction of embank-
ments, floodgates, canals and harbors. Surprisingly, the increase in disease frequency occurred 
despite a general drop in temperature, which began halfway into the sixteenth century, lasted 
for 150–200 years and was so pronounced that it was termed the Little Ice Age. The area of 
malaria distribution was the greatest it had ever been at the end of the nineteenth and the 
beginning of the twentieth centuries. At that time, malaria was highly prevalent in southern 
Europe while its northernmost limit ran along the 64° N parallel from central England to 
southern Norway, central Sweden and Finland and Northern European Russia.
The disappearance of malaria from Europe progressed from northwest to southeast and was 
the result of various contributing factors, including environmental changes, ecological and 
social developments, introduction of effective treatment and concerted human control efforts. 
One of the most important factors in lowering the prevalence of malaria is considered to have 
been the habitat separation of humans from cattle [6]. Malaria transmission in Europe has 
always been predominantly unstable, due to environmental, climatic and vector biology fac-
tors including strong zoophilic behavior. In such an epidemiological setting, it was relatively 
easy for human interventions to tip the fragile human-parasite balance against the parasite, 
leading to disease elimination.
The drainage, reclamation of swampland and improvements in water management in the fields 
drastically reduced the availability of mosquito breeding sites resulting in reduced mosquito pop-
ulations in many areas. Agricultural innovations led to better human overall health and an increase 
in animal populations. Animals were fed during the winter and kept in stables, byres and pigsties. 
These animal shelters and their occupants proved much more attractive for the main vector of 
malaria in most of Europe, the zoophilic An. atroparvus, diverting mosquitoes from the nearby 
human dwellings. Improvements in house construction and living standards played a significant 
role as well. Buildings where human living quarters and animal shelters were found together pro-
gressively disappeared. This human-domestic animal habitat separation played a major role in the 
decrease of malaria transmission. Finally, the extensive use of cinchona bark brought to Europe 
in the 1600s and the introduction of quinine in the 1820s further moderated disease transmission.
Nevertheless, in the beginning of the twentieth century, malaria still plagued a significant part 
of Europe, particularly the south. At the end of the nineteenth century, malaria was affecting 
approximately 10% of the Italian population, with annual cases in the range of two million 
and about 15,000–20,000 deaths per year [11]. The situation was somewhat worse in Greece. 
During his visit in 1906, Ronald Ross was surprised to discover that 65% of the children in 
the particularly malarious area around lake Copais in Voiotia were suffering from the disease 
[12]. The Greek-Turkish War in Asia Minor in 1922 and the tragic events that led to a back-
wave of 1,300,000 Greek refugees were followed by an increase in the outbreaks and the death 
toll of malaria in the late 1920s. Α communication from Greece to the WHO reported that, in 
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the 1930s, P. falciparum, P. vivax and P. malariae all occurred in the country; the annual attack 
rate was estimated at 15–30% of the total population, and the mortality rate was 73.7 deaths 
per 100,000 inhabitants. Treatment required approximately 30 tons of quinine each year [13]. 
In 1924, the League of Nations established the Malaria Commission to conduct research and 
strategize the control of malaria. The socioeconomic devastation and mass displacements 
caused by World War II interrupted the implementation of national elimination programs 
and destroyed environmental engineering works that had reduced transmission, setting back 
malaria control efforts. Control interventions, drug therapy and insecticide spraying resumed 
successfully in the late 1940s, and the World Health Organization certified the achievement of 
malaria eradication in Hungary in 1963, followed by Spain in 1964, Bulgaria in 1965, Poland 
and Romania in 1967, the Netherlands and Italy in 1970, Yugoslavia and mainland Portugal 
in 1973. In 1975, the last focus of indigenous malaria reported from Macedonia in Greece had 
been extinguished and Europe was malaria free for the first time in history.
3. Malaria in Europe: current situation
Europe, in the most prevalent definition of the term, is distinct from the area currently desig-
nated “the WHO European Region” which comprises all countries of the European Union (EU), 
the Balkans, South Caucasus and Central Asia and the Russian Federation, Israel and Turkey 
(53 countries in all), some of which do not belong to Europe geographically. The European 
Centre for Disease Prevention and Control (ECDC) issues annual epidemiological reports on 
malaria in Europe based on data retrieved from the European Surveillance System (TESSy) that 
collects, analyzes and disseminates data on communicable diseases that generally originate 
from national surveillance systems. Malaria is a notifiable disease in the EU and its reporting is 
compulsory in 24 countries, voluntary in France and Belgium and “not specified” in the United 
Kingdom (UK). Active disease surveillance is in place only in the Czech Republic, Slovakia, 
the UK, and in high-risk areas in Greece. The latest available data on the number of malaria 
cases in EU and European Economic Area (EEA) countries reported to the ECDC are shown in 
Table 1. Nearly all malaria cases (99.9%) are currently imported by international travelers and 
immigrants [14, 15]. Of the 31 European countries reporting to the ECDC the highest number of 
confirmed cases in 2014 and 2015 were reported from France (n = 2299 and 2500) and the United 
Kingdom (n = 1510 and 1397, respectively) (Table 1). Imported malaria in these countries was 
mainly linked to travel to West Africa, particularly for the purpose of visiting friends and rela-
tives residing in countries and European territories endemic for malaria, such as Mayotte and 
French Guiana [15]. The causative species depends on the area the parasite is imported from 
and the largest proportion is identified as P. falciparum [16]. Similarly, the incidence and spe-
cies distribution in refugees and immigrants reflects the local epidemiology in their country 
of origin and along the migration route they followed. Notably, many immigrants prefer to 
remain unnoticed by the authorities until they reach the country they intend to request asylum 
from, and therefore a significant proportion of malaria cases in this population, possibly even 
half of them are thought to remain unreported [17]. Permanent foreign residents that have 
settled in European countries and regularly return to their malaria endemic country of origin 
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Countries 2011 2012 2013 2014 2015
Cases 
confirmed 
(reported)
Rate** Cases 
confirmed 
(reported)
Rate Cases 
confirmed 
(reported)
Rate Cases 
confirmed 
(reported)
Rate Cases 
confirmed 
(reported)
Rate
Austria 7 0.1 28 0.3 42 0.5 68 0.8 81 0.9
Belgium 184 1.7 206 1.9 253 2.3 235 2.1 276 2.5
Bulgaria 8 0.1 16 0.2 8 0.1 10 0.1 20 0.3
Croatia — — 23 0.5 0 0.0 6 0.1 7 0.2
Cyprus 6 0.7 1 0.1 3 0.3 8 0.9 3 0.4
Czech Republic 28 0.3 25 0.2 27 0.3 30 0.3 29 0.3
Denmark — — — — — — — — — —
Estonia 1 0.1 6 0.5 3 0.2 3 0.2 4 0.3
Finland 33 0.6 46 0.9 38 0.7 39 0.7 39 0.7
France 1891 — 1851 — 2165 — 2299 — 2500 —
Germany 0 (562) 0 (0.7) 0 (547) 0 
(0.7)
0 (637) 0 
(0.8)
— — 0 (1063) 0
Greece 92 0.8 95 0.9 25 0.2 38 0.3 84 0.8
Hungary 10 0.1 5 0.1 5 0.1 15 0.2 12 0.1
Iceland — — — — — — — — — —
Ireland 61 1.3 65 1.4 71 1.5 79 1.7 82 1.8
Italy — — — — — — — — — —
Latvia 4 0.2 3 0.1 4 0.2 6 0.3 1 0.1
Liechtenstein — — — — — — — — — —
Lithuania 3 0.1 6 0.2 8 0.3 5 0.2 8 0.3
Luxembourg 3 0.6 7 1.3 4 0.7 3 0.5 1 0.2
Malta 1 0.2 2 0.5 5 1.2 3 0.7 7 1.6
Netherlands 253 1.5 194 1.2 162 1.0 276 1.6 340 2.0
Norway 30 0.6 37 0.7 72 1.4 120 2.3 94 1.8
Poland 14 0.0 21 0.1 36 0.1 19 0.0 29 0.1
Portugal 67 0.6 71 0.7 117 1.1 144 1.4 194 1.9
Romania 40 0.2 32 0.2 43 0.2 47 0.2 30 0.2
Slovakia 1 0.0 6 0.1 4 0.1 5 0.1 0 0.0
Slovenia 6 0.3 7 0.3 3 0.1 7 0.3 5 0.2
Spain 405 0.9 421 0.9 518 1.1 688 1.5 706 1.5
Sweden 95 1.0 85 0.9 119 1.2 354 3.7 250 2.6
United Kingdom 1677 2.7 1378 2.2 1501 2.3 1510 2.3 1397 2.2
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to visit friends and relatives (also known as VFRs) are currently the most significant high-risk 
population for malaria importation, for geographic and behavioral reasons. Specifically, they 
visit endemic areas frequently, often stay in rural areas with poor health infrastructure for 
longer periods than tourists do, do not usually seek pre-travel medical advice and have poor 
compliance with malaria chemoprophylaxis and protection measures. P. falciparum and much 
less so P. ovale and P. malariae are usually imported from sub-Saharan Africa, particularly West 
Africa, whereas P. vivax from Asia and areas of South America. P. falciparum is usually detected 
shortly after the patient’s arrival, due to its prominent clinical presentation, whereas P. vivax 
and P. malariae might remain undetected for a significant amount of time. Obviously, the pos-
sibility that individuals infected with malaria may remain undetected for several months after 
arrival to Europe could be a significant risk factor for local transmission, particularly regarding 
P. vivax for which competent vectors are still widely distributed across the continent.
Europe has been considered malaria free since 1975, as was the rest of the WHO European 
Region at that time, except for Turkey. However, in the late 1980s and early 1990s, autochtho-
nous malaria transmission chiefly due to P. vivax resumed in the Transcaucasian countries, the 
Central Asian republics and less so in the Russian Federation, most likely due to mass popula-
tion movements, socio-economic challenges, agricultural and developmental schemes and the 
neglect of malaria prevention and control services. The Roll Back Malaria (RBM) Initiative in 
1998 and the Tashkent declaration for “The move from malaria control to elimination” in 2005 
[18] seem to have successfully reached their targets. According to WHO, the WHO European 
Region reported zero indigenous malaria cases in 2015, thus achieving its set goal of disease 
elimination [19]. As far as the European continent itself is concerned, since the late 1990s, spo-
radic autochthonous malaria cases occurred in several countries, caused by infection of local 
mosquitoes by travelers or immigrants from endemic regions. Locally transmitted malaria 
cases have been reported in Spain [20], Germany [21], the Netherlands [22], France [23], Italy 
[24] and Greece [25]. More recently, 5 cases were reported to the ECDC as locally acquired in 
2014, 7 in 2015, 10 cases in 2016 and 17 in 2017 recorded from 8 different countries (Table 2). 
Epidemiology and modes of transmission included congenital transmission from mothers 
Countries 2011 2012 2013 2014 2015
Cases 
confirmed 
(reported)
Rate** Cases 
confirmed 
(reported)
Rate Cases 
confirmed 
(reported)
Rate Cases 
confirmed 
(reported)
Rate Cases 
confirmed 
(reported)
Rate
EU/EEA 4920 
(5482)
0.8 
(1.0)
4637 
(5184)
0.7 
(0.9)
5236 
(5873)
0.8 
(1.0)
6017 1.0 6199 1.0
*ECDC = European Centre for Disease Prevention and Control.
**Rate denotes number of cases per 100,000 population. Reporting in France is voluntary and surveillance coverage is 
not nationwide.
Note: • 99.9 and 99.8% of cases for which travel information was provided were travel related in 2014 and 2015 
respectively.
Source: [14, 15].
Table 1. Malaria cases in the European Union (EU) and European economic area (EEA) reported to the ECDC* during 
2011–2015: confirmed cases (reported cases) and rate per 100,000 population.
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infected in an endemic country, induced malaria following a transplant from a donor who 
had traveled to an endemic country, introduced malaria due to residence near imported cases 
and “suitcase malaria” [26–28]. Among the locally acquired cases in 2017 included a fatal case 
of falciparum malaria in a four-year-old diabetic girl in Italy. Epidemiological investigations 
identified hospitalization of this case along with two other patients infected with P.  falciparum 
Year Total cases Country (no. of 
cases)
Parasite species Mode of transmission-epidemiology
2014 5 France (2) Unspecified Undocumented residents, travel to endemic 
region possible
Spain (3) P. falciparum Congenital (mother originally from Equatorial 
Guinea)
P. malariae Induced (kidney transplant from traveler to 
Equatorial Guinea)
P. vivax Introduced (residence near imported case)
2015 7 Greece (6) P. vivax Mosquito-borne, autochthonous in receptive 
rural areas, presence of patients from endemic 
countries in the area
Belgium (1) P. falciparum “Suitcase malaria”
Netherlands (1) P. vivax Congenital (mother: an Eritrean refugee)
2016 10 Greece (6) P. vivax Mosquito-borne, introduced
France (2) Unspecified Mosquito-borne, introduced or airport malaria
Spain (1) Unspecified
Lithuania (1) Unspecified
2017 17 (until 
15/12/2017)
France (2) P. falciparum Mosquito-borne, in the area where P. falciparum 
malaria imported from Burkina Faso occurred
Greece (7) P. vivax (6) Mosquito-borne, introduced
P. falciparum (1) Nosocomial, mosquito-borne or iatrogenic 
(not transfusion), patient recently hospitalized 
in ward where a patient was treated for P. 
falciparum malaria.
Italy (5) P. falciparum (1) Mosquito-borne or nosocomial, fatal, 4 years 
old diagnosed with diabetes mellitus; two 
patients infected with P. falciparum were 
hospitalized in the same ward
P. falciparum (4) Mosquito-borne, patients originally from Africa
UK (3) P. vivax Mosquito-borne, contracted in Northern 
Cyprus
Source: [26–28].
Table 2. Locally acquired malaria cases in Europe during 2014–2017.
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in the same ward. Another case of potentially nosocomial P. falciparum transmission was 
reported from northwest Greece.
4. Risk of malaria re-emergence in Europe
The possibility of malaria re-emergence in Europe in the face of climatic and demographic 
changes was renewed in the 2000s partly aroused by reports of epidemics in neighboring 
Turkey and central Asia. The risk of malaria introduction in a given area, also known as its 
malariogenic potential, depends on three characteristics: receptivity, vector infectivity and 
vulnerability [29].
Receptivity depends on the presence of a competent vector, and ecological and climatic con-
ditions, conducive to vector survival and proliferation. Vectorial capacity is determined by 
mosquito population density, life span, feeding preferences and duration of parasite develop-
ment (sporogony). Several Anopheles species capable of transmitting malaria are still abundant 
across Europe. The geographical distribution of the European dominant malaria vector spe-
cies and their main bionomical characteristics are shown is Figure 1 and Table 3, respectively. 
The most widely distributed belong to the Anopheles maculipennis Subgroup. Historically, A. 
atroparvus was the primary malaria vector in most of northern, western and central Europe 
[30]. It occurs along the coast of the Atlantic Ocean, from south Sweden to Portugal and Spain, 
around the Baltic Sea and variably in central Europe and the Balkans. Its distribution in Europe 
has contracted with the disappearance of coastal marshlands and increasing water pollution. 
An. labranchiae and An. sacharovi were the most important malaria vectors in southern Europe, 
the Balkans, Italy and Greece. An. labranchiae has been reported from Corsica, the coastal 
areas of Italy, Sardinia, Sicily, the Istrian Peninsula and the Dalmatian Coast of Croatia; it 
also occurs in North Africa. Once endemic in southern coastal Spain, An. labranchiae has since 
disappeared after abandonment of rice cultivation and desiccation of wetlands. An. sacharovi 
is encountered in Greece, the Balkans, south Russia, Turkey and the Middle East [6, 31, 32]. 
Other species considered malaria vectors of minor importance are also currently encountered 
in Europe. Some belong to the An. maculipennis Subgroup (An. messeae, An. maculipennis s.s. An. 
melanoon); others included An. algeriensis, An. claviger, An. hyrcanus, An. plumbeus, An. superpic-
tus. The eradication campaigns of the twentieth century led to severe reduction of Anopheles 
numbers but failed to achieve complete eradication. Over time, in certain areas, Anopheles 
populations recovered to initial levels giving rise to the phenomenon known as “anophelism 
without malaria” which essentially signifies the presence of Anopheles mosquitoes in formerly 
malarious areas of Europe where malaria no longer occurs.
The climate of south European countries around the Mediterranean Sea, characterized by 
mild-wet winters and hot-dry summers, is suitable for malaria transmission, whereas in 
northern Europe ambient temperatures permit outdoor parasite development only during the 
summer. To the extent that climate change can be predicted with any degree of certainty, it is 
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Figure 1. Geographical distribution of dominant malaria vector species in Europe. A: An. atroparvus (blue), An. labranchiae 
(orange), B: An. superpictus (yellow), C: An. messeae (green) and An. sacharovi (purple). Source: updated maps from Ref. [6].
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Species Breeding habitats Feeding Resting 
habits
Overwintering Susceptibility to 
P. falciparum
An. atroparvus 
van Thiel
Fresh water, brackish 
and tolerates 
saltwater. Marshes, 
ditches, ground 
pools, river margins, 
streams, rock pools, 
rice fields, even used 
tyres, sun-exposed 
habitats.
Opportunistic 
feeder: mostly 
zoophilic, but 
anthropophilic too, 
Exophagic.
Exophilic Hibernation of 
female incomplete 
(periodic feeding), 
gonotrophic 
disassociation 
(without 
oviposition)
Refractory to 
Asian and African 
P. falciparum 
but competent 
in supporting a 
European strain
An. 
labranchiae 
Falleroni
Mainly freshwater 
habitats, occasionally 
brackish water and 
lagoons. Warmer 
environment than An. 
atroparvus. Sunlit rock 
holes, pits, ditches, 
drains, canals, slow 
flowing streams/
rivers, ground pools, 
ponds, lakes, rice 
fields.
Opportunistic: 
zoophilic, but 
anthropophilic too
Mostly 
exophilic
Hibernation 
of female 
incomplete (with 
occasional blood 
feeding without 
ovipositioning) 
and complete 
(without 
feeding and 
nongonoactive)
Refractory 
to tropical P. 
falciparum strains
Historical evidence 
of natural infection 
with European 
strains
Experimental 
evidence of 
infection with some 
strains of African P. 
falciparum
An. messeae 
Falleroni
Shaded, clear, still or 
slow flowing fresh 
water, Lake margins, 
marshes, swamps, 
ditches.
Mostly zoophilic, 
exophagic
Endophilic Hibernation of 
female with full 
diapause, do not 
feed during the 
winter
Refractory 
to tropical P. 
falciparum strains
An. sacharovi 
Favre
Brackish and fresh 
still or flowing water. 
Sunlit sites with 
aquatic vegetation 
such as swamps, 
marshes, river 
margins, springs, 
seepages, pools, 
ditches, irrigation 
canals, small water 
collections.
Opportunistic 
feeder but mainly 
anthropophilic; 
exophagic and 
endophagic
Endophilic Hibernation of 
female incomplete 
(periodic feeding), 
gonotrophic 
disassociation 
(without 
oviposition)
Essentially 
refractory to 
tropical P. 
falciparum strains 
(inconclusive 
experimental 
results)
Historical evidence 
of natural infection 
with European 
strains
An. 
superpictus 
Grassi
Brackish and fresh 
still or flowing water 
in full sunlit. Small 
pools in river beds, 
irrigation canals, 
storage tanks, rice 
fields, ditches, 
borrow pits.
Mostly zoophilic 
and exophagic
Mostly 
endophilic
No information No information
Source: [6, 32].
Table 3. Bionomical characteristics of the European dominant malaria vector species.
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expected to encompass changes in temperature, precipitation and the intensity and frequency 
of extreme weather phenomena. By the end of the twenty-first century, with continuing tem-
perature increase, fewer cold and more frequent hot temperature extremes are projected to 
occur on daily and seasonal timescales, while heat waves are likely to last longer and occur 
more often. It is estimated that many regions will probably experience more frequent and 
intense extreme precipitation events [33]. Occurrence of higher temperatures for longer peri-
ods during the summer may increase chances for malaria transmission in certain previously 
inhospitable areas. Malaria endemicity however is not simply a matter of the right tempera-
ture. Climate change is but one element in a complex epidemiological setting and other com-
ponents such as human activity are probably more important determinants.
Infectivity reflects the vector competence to replicate and transmit a particular Plasmodium 
species or strain. Replication is assessed by the presence of oocysts in the mosquito midgut 
and capability to transmit is determined by the presence of sporozoites in its salivary glands. 
European Anopheles exhibit variable sensitivity to Plasmodium strains from malaria endemic 
regions. Members of the An. maculipennis Subgroup have been found capable of developing 
P. vivax sporozoites following an infected blood meal, but competence is difficult to evaluate 
given the absence of reliable P. vivax gametocyte culture. On the whole, although there is 
substantial knowledge on the vectorial potential of numerous tropical and subtropical mos-
quito species, corresponding data on European indigenous species are scarce [34]. Earlier 
studies have shown European An. atroparvus and An. labranchiae populations to be refrac-
tory to infection by tropical strains of P. falciparum, although not universally [35–38]. An. 
labranchiae has been an important malaria vector in the central and western Mediterranean, 
where both P. vivax and P. falciparum occurred in the past, and there is historical data from 
the early twentieth century confirming the existence of naturally infected Anopheles in the 
area, however, without specifying the species. A recent experimental study reported that 
An. maculipennis s.l. from Corsica were successfully infected with the NF54 African strain of 
P. falciparum; furthermore, sporozoites were detected in the salivary glands of some mosqui-
toes, indicating they were capable of transmission, albeit with very low competence [32]. An. 
labranchiae is thought to have been involved in autochthonous transmission of vivax malaria 
in southern Italy and possibly in Corsica in 2011 and 2006, respectively [39, 23].
A species that has recently become the focus of increasing attention is An. plumbeus (Stephens 
1828). It is widely distributed all over Europe (except in the far north regions), the Middle 
East and North Africa. An. plumbeus was originally known as a dendrolimnic species, encoun-
tered in forests and breeding almost exclusively in tree holes. Recent reports indicate that 
it has been adapting to human-made habitats, such as abandoned animal shelters, artificial 
water containers, septic tanks, sewage ditches, rainwater and liquid manure pits, and that 
it is becoming increasingly common in suburban and urban environments. It overwinters 
as an egg or larva, has a relatively long-life span (up to 2 months) and is an avid biter of 
reptiles, birds and mammals, while some populations have exhibited high anthropoph-
ily [30]. Experimental studies have shown it to be a competent vector for both P. vivax and 
P. falciparum [40–42]. Furthermore, it has been implicated in indigenous vivax and falciparum 
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malaria transmission in England and Germany, respectively [21, 43]. Its potential role as a 
vector under changing climatic conditions and availability of infected human reservoir can 
only be speculated at present.
Vulnerability depends on the introduction and maintenance of a human reservoir that can 
transmit the parasite gametocytes to the mosquito populations. A patient suffering from 
malaria becomes infective for mosquitoes upon the appearance of Plasmodium gametocytes in 
the peripheral blood. In P. vivax malaria, gametogenesis occurs early in the course of the infec-
tion, within 3 days from the onset of clinical disease, whereas in P. falciparum malaria game-
tocytes usually appear 10 days after blood invasion. Therefore, a patient with vivax malaria is 
usually infective to mosquitoes frequently even before presenting for medical assistance. The 
additional delays in diagnosis and treatment, which are common in non-endemic countries, 
allow more time for transmission of the parasite to the local Anopheles populations.
In the past few years, Europe has witnessed a dramatic increase in the number of refugees 
and migrants, which peaked in 2015, with 1,257,000 asylum applications, double that of the 
previous year, a trend that continued in 2016 and 2017 [44]. Recently, a substantial increase 
in the incidence of vivax malaria has been recorded in refugees seeking asylum in European 
countries. More specifically, from spring 2014 to summer 2015, 37 cases of vivax malaria were 
diagnosed in newly arrived Eritrean refugees in Germany. Notably, their treatment was com-
plicated by relapses due to difficulties in procuring primaquine for hypnozoite eradication, 
as the drug was not licensed in Germany [45]. During the same time, 105 malaria cases were 
recorded in Eritrean refugees in Sweden, of which 84 were due to P. vivax [46]. It is specu-
lated that the refugees contracted the disease either at home or somewhere along their route 
from Eritrea through Ethiopia and Sudan. Interestingly, a cluster of 15 vivax malaria cases in 
Eritrean refugees was observed in 2010 in Israel [47].
According to data from the European Agency for the Management of Operational Cooperation 
at the External Borders of the Member States of the European Union (Frontex), a truly explosive 
increase occurred in 2015 at the Eastern Mediterranean route with 885,386 migrants arriving in 
Europe through Turkey, compared to 50,830 the previous year. These originated mainly from 
Syria, followed by Afghanistan and Somalia, and landed on Greek Islands, primarily Lesbos [48].
At present, it is not feasible to make specific, valid predictions as to where malaria might re-
emerge, based on existing data. This occurrence will probably be determined by numerous fac-
tors besides vector presence, abundance and susceptibility to infection, inter alia possible climatic 
changes in the future, human interventions and population movements among others, none of 
which can be predicted with any degree of certainty. Recent experience has shown that indige-
nous cases and outbreaks in Europe typically occur around immigrants or travelers from endemic 
areas. Neither the settlement location nor the duration of stay of the various migrant populations 
is predictable, particularly in view of the uncertainty of the current migration crisis. Notably, the 
potential repercussions of an infectious human reservoir build-up in a previously endemic area 
conducive to malaria transmission were illustrated by a malaria outbreak experienced in Greece 
in recent years. Since malaria eradication in Greece in 1974, cases were mostly imported, with 
a few sporadic reports of autochthonous transmission in 1991, 1999 and 2000 [49]. Since 2009, 
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however, locally acquired P. vivax malaria cases and clusters began to appear consistently almost 
every year, peaking in the 2011 outbreak, when 42 cases were reported from several foci around 
the country [50]. Five potential malaria vectors including An. sacharovi occur in Greece whereas 
the country’s geomorphology and climate allow for temporary and permanent mosquito 
breeding sites. The period from May to October has been established as the most favorable for 
mosquito infectivity and transmission in the area. An important contributing factor for increased 
vulnerability and malaria occurrence was the presence of migrant farm workers from Pakistan 
and Afghanistan in the affected areas. Many of these resided in poor housing conditions, situ-
ated close to mosquito breeding sites. Moreover, if they fell ill they were often reluctant to uti-
lize the freely available healthcare services, due to their frequently illegal status, thus increasing 
the chance of parasite transmission to local Anopheles populations [50]. P. vivax isolates from 
the affected areas were genotyped revealing a number of different strains [51]. Furthermore, 
there was indication of sustained transmission for two consecutive years at least in one focus; 
an observation that has truly unsettling implications in light of the current financial depression 
and immigration crisis the country is facing [51]. The Greek public health authorities initiated 
control efforts that focused on training of medical professionals to ensure early detection and 
treatment, vector control, surveillance, active case detection and public education. Finally, a mass 
drug administration program to immigrants living in the affected areas was also implemented 
[52]. The CDC has recently issued guidelines for the presumptive pre-departure treatment of 
asymptomatic malaria in refugees from sub-Saharan Africa [53]. Similar measures could be 
implemented for immigrants arriving in Europe from malaria endemic countries, which should 
include screening for malaria among the newly arrived to prevent clinical malaria in this popula-
tion and curtail the possibility of transmission to local mosquitoes. An additional measure one 
should take into account when considering malaria prevalence in immigrants, is the existence 
of asymptomatic individuals with sub-microscopic P. falciparum parasitaemia, and the fact that 
asymptomatic carriers of Plasmodium vivax liver hypnozoites are impossible to detect with any of 
the currently available methods.
There is no common malaria treatment policy currently adopted by all European countries. 
Treatment regimens are based on WHO recommendations and vary from country to country, 
occasionally even between centers within the same country. There is extensive heterogeneity 
in the management of imported falciparum malaria in Europe for which discussions toward a 
consensus for management standardization of malaria might be beneficial [54]. P. falciparum sus-
ceptibility to antimalarials is not assessed in the laboratory; rather it is extrapolated based on the 
geographical origin of the infecting strain, and national or WHO recommendations are followed 
accordingly [55, 56]. The issue of antimalarial drug resistance does not constitute an imminent 
threat for Europe. If any, it might constitute a threat to individual patient health, chiefly when 
imported P. falciparum is involved, but given that disease prevalence in Europe is extremely low 
(even taking immigrants into account), this issue currently has no public health relevance.
Regarding the susceptibility to insecticides of European putative and confirmed malaria vec-
tor species in countries where malaria is not endemic, data originates from small-scale studies 
and is limited [57, 58]. As of this date, there is no systematic report on the status of Anopheles 
susceptibility to insecticides in the European Region.
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5. Concluding remarks
Increasing concern about emerging infectious diseases has rekindled scientific and public inter-
est in malaria. Reminders of widespread malaria endemicity across Europe in the past, the 
continuing presence of known and emerging vectors and the reality of a substantial population 
influx—including potential parasite carriers—from endemic areas combined with projections 
of climate change have raised the question of a possible re-emergence of malaria foci in the 
continent. Taking geomorphological, climatic and entomological factors into account, the risk 
of malaria resurgence appears to differ in various parts of Europe. In the northwest, manmade 
environmental changes in housing and livestock farming has led to continuing loss of breed-
ing sites for An. atroparvus, the major vector in the area. In the event of a temperature rise 
in the region, mosquito survival would increase and Plasmodium sporogony would be facili-
tated, but the scarcity of mosquito vectors and the tendency of relevant species to preferentially 
feed on animals create an epidemiological setting where there is practically no considerable 
threat of renewed autochthonous transmission. An. plumbeus, with its reported adaptability 
to urban habitats and increased anthropophily could assume a more epidemiologically sig-
nificant role as a vector in the future. Even so, however, provided that healthcare retains its 
current high standards, timely treatment of patients would prevent the buildup of an infectious 
human reservoir, thus preventing establishment of the parasite in the local mosquito popula-
tions. An influx of human gametocyte carriers could result in limited local transmission around 
untreated patients, which would be spatially and temporally restricted, provided of course that 
local healthcare services are aware of the risk and effective in early case detection and treatment.
Regarding Southern Europe, there can be no doubt that current climatic conditions are favor-
able for malaria transmission in selected areas, where competent mosquito vectors like An. 
labranchiae and An. sacharovi are also present in epidemiologically significant densities. The 
recent occurrence of sporadic autochthonous cases and minor outbreaks has demonstrated that 
previously endemic malaria parasite species, principally P. vivax, are still theoretically trans-
missible in the area. A future temperature rise might expand vector distribution and abun-
dance, increasing the risk for malaria transmission in the long run, but such a change is unlikely 
to develop overnight. However, two variables that could unpredictably influence vulnerability 
south of Europe are changing rapidly, that is, population movement and economic hardship. It 
was only 20 years ago that Turkey and central Asia experienced epidemic malaria resurgence 
from small residual reservoirs, demonstrating the catalytic impact mass population displace-
ment and socioeconomic upheaval could have on malaria epidemiology in vulnerable areas. 
Europe is currently witnessing an unprecedented influx of immigrants from malaria endemic 
areas, many of which are asymptomatic carriers of dormant Plasmodium forms. It is believed that 
the highly organized and efficient European healthcare services can avert malaria re-establish-
ment through prompt diagnosis and treatment, provided that they maintain their current high 
operational standards. However, nowadays malaria is being imported into Europe through 
areas severely affected by economic recession, which is putting an increasing strain on available 
health resources for natives and migrants alike. Therefore, although the resurgence of malaria 
in Europe is currently unlikely, it is crucially important to improve, maintain and financially 
support disease awareness, diagnostic expertise, clinical competence, sustained surveillance 
and vector control to ensure that malaria is not allowed a foothold in the European continent.
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Finally, it would be remiss not to mention that malaria history has repeatedly demonstrated 
the precariousness of malaria control. To quote Bruce-Chwatt and de Zulueta [59] “… any 
deterioration of organized services by a major catastrophe or war may bring back to Europe a series of 
communicable diseases among which malaria would not be the last.” Indeed “…the simple truth is 
that there will be no safety from any infectious disease as long as vast reservoirs of pathogens remain in 
parts of our shrinking world in which the Atlantic and the Pacific Oceans are figuratively demoted to 
the status of intercontinental rivers.”
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